Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women

Resnik, Jamie L.; Hong, Christina; Resnik, Robert; Kazanegra, Radmila; Beede, Jennifer; Bhalla, Vikas; Maisel, Alan S.

doi:10.1016/j.ajog.2004.12.006

Cited by 150 publications

(129 citation statements)

References 24 publications

Supporting

Mentioning

111

Contrasting

Unclassified

Order By: Relevance

“…In this manner, we compared the impact of preeclampsia prediction of NT-proBNP with notch positivity together with elevated PI values. Unlike in other studies, NTproBNP levels were not different with respect to the development of preeclampsia in later pregnancy [8,13,22]. The lack of difference may be related to some reasons.…”

Section: Discussioncontrasting

confidence: 80%

The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia

Uyar¹,

Kurt²,

Demirtaş

et al. 2014

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 80%

The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia

Uyar¹,

Kurt²,

Demirtaş

et al. 2014

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

“…Seven studies reported on BNP levels,78, 79, 80, 81, 82, 83, 84 of which three were applicable for a meta‐analysis ( Figure 5). 78, 79, 80 …”

Section: Resultsmentioning

confidence: 99%

Shared biomarkers between female diastolic heart failure and pre‐eclampsia: a systematic review and meta‐analysis

et al. 2017

View full text Add to dashboard Cite

Evidence accumulates for associations between hypertensive pregnancy disorders and increased cardiovascular risk later. The main goal of this study was to explore shared biomarkers representing common pathogenic pathways between heart failure with preserved ejection fraction (HFpEF) and pre‐eclampsia where these biomarkers might be potentially eligible for cardiovascular risk stratification in women after hypertensive pregnancy disorders. We sought for blood markers in women with diastolic dysfunction in a first literature search, and through a second search, we investigated whether these same biochemical markers were present in pre‐eclampsia.This systematic review and meta‐analysis presents two subsequent systematic searches in PubMed and EMBASE. Search I yielded 3014 studies on biomarkers discriminating women with HFpEF from female controls, of which 13 studies on 11 biochemical markers were included. Cases had HFpEF, and controls had no heart failure. The second search was for studies discriminating women with pre‐eclampsia from women with non‐hypertensive pregnancies with at least one of the biomarkers found in Search I. Search II yielded 1869 studies, of which 51 studies on seven biomarkers were included in meta‐analyses and 79 studies on 12 biomarkers in systematic review.Eleven biological markers differentiated women with diastolic dysfunction from controls, of which the following 10 markers differentiated women with pre‐eclampsia from controls as well: C‐reactive protein, HDL, insulin, fatty acid‐binding protein 4, brain natriuretic peptide, N terminal pro brain natriuretic peptide, adrenomedullin, mid‐region pro adrenomedullin, cardiac troponin I, and cancer antigen 125.Our study supports the hypothesis that HFpEF in women shares a common pathogenic background with pre‐eclampsia. The biomarkers representing inflammatory state, disturbances in myocardial function/structure, and unfavourable lipid metabolism may possibly be eligible for future prognostic tools.

show abstract

“…It should be arranged urgently in the setting of suspected HF in the pregnant patient. Measurement of plasma B-type natriuretic peptide may be useful in confirming a diagnosis of HF when the diagnosis is not clear (77)(78)(79). Bloodwork should include complete blood The use of x-ray in pregnant women (with fetal shielding in place) should be used only if judged clinically essential.…”

Section: Evaluation Of Hf In Pregnancymentioning

confidence: 99%

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

Howlett¹,

McKelvie²,

Costigan³

et al. 2010

Canadian Journal of Cardiology

100

View full text Add to dashboard Cite

Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women

Cited by 150 publications

References 24 publications

The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia

The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia

Shared biomarkers between female diastolic heart failure and pre‐eclampsia: a systematic review and meta‐analysis

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

Contact Info

Product

Resources

About